China Resources Pharmaceutical Group announces executive board changes

China Resources Pharmaceutical Group Limited announced that Deng Rong will resign as an executive director and a member of the executive committee, effective September 18, 2025, due to other work arrangements. Deng will continue as the chief financial officer. Concurrently, Liu Changan has been appointed as an executive director and a member of the executive committee, effective on the same date. Liu, 52, has been a director of China Resources Pharmaceutical Holdings Company Limited since October 2024 and will receive a pre-tax basic monthly salary of RMB70,100.

Following these changes, the board will comprise Bai Xiaosong as chairman and executive director; Cheng Jie and Liu Changan as executive directors; Guo Wei, Sun Yongqiang, Wang Yuhang, Guo Chuan, and Jiao Ruifang as non-executive directors; and Chiu Mun Wai, Fu Tingmei, Zhang Kejian, and Shi Luwen as independent non-executive directors.

The board committee memberships will also be updated. Liu Changan will serve as a member of the executive committee. Bai Xiaosong will chair the executive and nomination committees, while Cheng Jie will be a member of the executive and corporate governance committees.